Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound
Key Takeaways After a tough year for Walgreens investors in 2024, shares may have appeared poised to start 2025 on strong note after the company’s first-quarter results topped expectations. However, analysts have remained cautious, mostly keeping “hold” or “sell” ratings on the pharmacy retailer’s stock. A lawsuit filed late last week by the Department of